In our study, we correlate the in vitro and in vivo exosome-mediated stimulation of CML growth and survival with a deregulated activation of both ERK and Akt pathways. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.